Ligand Pharmaceuticals (LGNYZ) Shares Issued (2016 - 2025)
Historic Shares Issued for Ligand Pharmaceuticals (LGNYZ) over the last 16 years, with Q2 2025 value amounting to $8.2 million.
- Ligand Pharmaceuticals' Shares Issued fell 1374.58% to $8.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $53.2 million, marking a year-over-year increase of 5298.97%. This contributed to the annual value of $65.6 million for FY2024, which is 19217.75% up from last year.
- Latest data reveals that Ligand Pharmaceuticals reported Shares Issued of $8.2 million as of Q2 2025, which was down 1374.58% from $4.2 million recorded in Q1 2025.
- Over the past 5 years, Ligand Pharmaceuticals' Shares Issued peaked at $26.5 million during Q1 2021, and registered a low of $347000.0 during Q1 2022.
- Its 5-year average for Shares Issued is $7.6 million, with a median of $4.3 million in 2021.
- As far as peak fluctuations go, Ligand Pharmaceuticals' Shares Issued soared by 619287.41% in 2021, and later plummeted by 9869.02% in 2022.
- Ligand Pharmaceuticals' Shares Issued (Quarter) stood at $4.3 million in 2021, then plummeted by 67.26% to $1.4 million in 2022, then skyrocketed by 365.81% to $6.5 million in 2023, then surged by 196.31% to $19.3 million in 2024, then plummeted by 57.39% to $8.2 million in 2025.
- Its Shares Issued was $8.2 million in Q2 2025, compared to $4.2 million in Q1 2025 and $19.3 million in Q4 2024.